Identifying ZBTB11 as A Potential Drug Target (G27107)

Target Name: ZBTB11

NCBI ID: G27107

ZBTB11

Identifying ZBTB11 as A Potential Drug Target

ZBTB11 (MGC133303) is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the ZBTB family, which includes several related proteins that are involved in the regulation of stem cell proliferation and differentiation.

Recent studies have identified ZBTB11 as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because ZBTB11 has been shown to play a role in the regulation of cell growth, proliferation, and survival, and is often abnormal expressed in many diseases.

One of the key reasons for the potential of ZBTB11 as a drug target is its ability to interact with a variety of different signaling pathways. For example, ZBTB11 has been shown to be involved in the regulation of theNotch signaling pathway, which is involved in the regulation of stem cell proliferation and differentiation. This is important because many diseases, including cancer, are caused by disruptions in the regulation of stem cells.

Another reason for the potential of ZBTB11 as a drug target is its role in the regulation of the Wnt signaling pathway. Wnt signaling is involved in the regulation of cell growth and survival, and is important for the development and maintenance of tissues in the body. ZBTB11 has been shown to be involved in the regulation of Wnt signaling, which suggests that it may be a useful target for drugs that are designed to treat diseases that are characterized by disruptions in this pathway.

In addition to its involvement in these signaling pathways, ZBTB11 has also been shown to be involved in the regulation of a variety of other signaling pathways that are important for the development and maintenance of tissues in the body. For example, ZBTB11 has been shown to be involved in the regulation of the TGF-β signaling pathway, which is involved in the regulation of cell growth and differentiation. This is important because many diseases, including cancer, are caused by disruptions in the regulation of cell growth and differentiation.

Overall, ZBTB11 is a protein that has been identified as a potential drug target for a variety of diseases. Its ability to interact with a variety of different signaling pathways makes it an attractive target for drugs that are designed to treat a wide range of conditions. Further research is needed to fully understand the role of ZBTB11 in the regulation of cell growth and differentiation, and to identify the best ways to use it as a drug.

Protein Name: Zinc Finger And BTB Domain Containing 11

Functions: May be involved in transcriptional regulation

The "ZBTB11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets